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ABSTRACT 
Colchicine, both in vitro and in vivo, inhibits secretion of albumin and other plasma 
proteins.  In vitro, secretion by rat liver slices is inhibited at  l0 -8 M  with maximal 
effect at l0 -5 M. Inhibition of secretion is accompanied by a concomitant retention 
of  nonsecreted  proteins  within  the  slices.  Colchicine  does  not  inhibit  protein 
synthesis at these concentrations. Vinblastine also inhibits plasma protein secretion 
but lumicolchicine, griseofulvin, and cytochalasin B do not. Colchicine also acts in 
vivo at 10-25 #mol/100 g body weight. Inhibition of secretion is not due to changes 
in the  intracellular nucleotide phosphate levels. Colchicine, administered intrave- 
nously, acts within 2  min and its inhibitory effect lasts for at least 3 h.  Colchicine 
has no effect on transport of secretory proteins in the rough or smooth endoplasmic 
reticulum  but  it  causes  these  proteins  to  accumulate  in  Golgi-derived secretory 
vesicles. 
Plasma proteins, produced by the liver, are synthe- 
sized on  polysomes attached to the membrane of 
the endoplasmic reticulum (ER) ~ (12,  14,  29,  30, 
37)  and  are then  transported, stepwise, from  the 
lumen of the rough ER (RER) to the smooth ER 
(SER)  and to the Golgi complex. Finally, Golgi- 
derived vesicles, which contain the secretory pro- 
teins,  migrate  to the  sinusoidal cell surface,  fuse 
with  the  plasma  membrane,  and  empty  their 
contents in the space of Disse (13, 25,  26). While 
this  intracellular  pathway  has  now  been  well 
established, there is still a  paucity of information 
~Abbreviations  used  in  this  paper:  ER,  endoplasmic 
reticulum; Golgi I, II, and  111, light, intermediate,  and 
heavy Golgi fractions, respectively, KRB, Krebs-Ringer 
bicarbonate medium;  RER,  rough endoplasmic  reticu- 
lum or rough microsomal  fraction;  SER, smooth endo- 
plasmic  reticulum  or  smooth  microsomal  fraction; 
TKM, 10 mM Tris-HCl pH 7.4, 25 mM KCI, and 5 mM 
MgCI2; TSH, thyroid-stimulating  hormone; VLDL, very 
low density lipoproteins. 
on how the secretory proteins are moved from one 
cellular compartment to another. The use of drugs, 
which  inhibit  the  secretory  process  at  distinct 
locations in the cell, may prove valuable for more 
detailed studies of specific steps in  secretion and 
may  lead  eventually  to  an  understanding  of the 
molecular  basis  of  the  mechanism  involved  in 
intracellular transport. 
It has been demonstrated that certain alkaloids, 
such  as colchicine, affect secretion in a variety of 
tissues.  Some  examples are the  inhibition of the 
secretion of insulin (16),  thyroxine (41, 425, sali- 
vary gland  mucin  (32),  hepatic very low density 
lipoproteins (VLDL) (17,  365, that of the conver- 
sion  of  procollagen  to  collagen  (10)  (which  is 
assumed to be dependent on secretory discharge), 
that of the epinephrine-stimulated release of amy- 
lase from the parotid (55, and that of the acetylcho- 
line-stimulated release of catecholamine from the 
adrenal medulla (7, 27). Colchicine has also been 
shown to inhibit the release of lysosomal enzymes 
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instance  in  which  colchicine  affects  discharge. 
Exceptions  have  been  recorded,  however,  since 
glucagon  secreted  by  isolated  pancreatic  islets 
(guinea pig) is enhanced, rather than depressed, by 
colchicine (8) and since the drug does not affect the 
secretion  of  immunoglobulins  by  mouse  plas- 
macytomas (24), the potassium-stimulated release 
of catecholamines  from  the  adrenal  medulla  (7), 
nor the thyroid-stimulating hormone (TSH) secre- 
tion by the pituitary (38). 
This paper reports the results of a detailed study 
of the  action  of colchicine and other functionally 
related agents in inhibiting, in vitro and in vivo, the 
secretion of albumin and other plasma proteins by 
rat liver.  We show that this drug does not impede 
the early steps in the secretory process, namely, the 
synthesis and the movement of secretory proteins 
from  the  RER  to  the  Golgi  complex,  but that  it 
inhibits late events which occur after the filling of 
Golgi-derived  secretory  vesicles  with  secretory 
protein  but  before  the  fusion  of the  vesicles with 
the sinusodiai plasma  membrane, 
A  preliminary  report  of some  of this work  has 
appeared  in abstract  form (31). 
MATERIALS  AND  METHODS 
Animals 
Young male rats 1120-175 g) were starved overnight 
before the experiments.  Ethanol was given by stomach 
tube  (0.6  g  ethanol as  a  50%  solution  per  100 g  body 
weight).  Colchicine or  radioactive amino acid  was  ad- 
ministered by intravenous injection into the femoral vein. 
Serial blood samples were obtained from the tail vein or 
by heart puncture when larger quantities were needed. 
Preparation  and Incubation of Liver Slices 
Slices,  approximately  0.5  mm  in  thickness,  were 
prepared with a Stadie-Riggs hand slicer. About 0.3 g of 
slices were incubated in 5 ml of Krebs-Ringer bicarbon- 
ate (KRB) saline supplemented with 0.21  M glucose and 
a  mixture of 20  amino  acids  (0.1 mM)  minus  leucine 
which was introduced as L-[U-~*C]leucine,  0.25 #Ci/ml, 
(sp act 348 mCi/mmol). After a pulse incubation of 7-9 
min at 37~  the slices were recovered by filtering out the 
medium; they were washed with 0.7 mM nonradioactive 
L-leucine  in 0.154 M  NaCI and reincubated at 37~  in 5 
ml of KRB containing 021  M glucose and a complete 0,1 
mM  mixture  of  21  nonradioactive  amino  acids.  The 
secreted  proteins  were  recovered  from  the  incubation 
medium  by  precipitation  with  TCA  or  by  immuno- 
precipitation, and the proteins retained within the tissue 
were  obtained  from  slices  washed  free  of  medium  by 
three successive treatments with 0.154 M  NaCI. 
Cell Fractionation Procedures 
The livers were homogenized in 5 vol of ice-cold  0.25 
M sucrose with five to eight strokes of a Potter-Elvejhem 
homogenizer with a Teflon pestle, motor driven at 1,0013 
rpm. The homogenate was cleared of cell debris, nuclei, 
and  mitochondria by centrifugation at  10,000  g  for  10 
min.  A  total  microsomal  fraction,  i.e.  a  mixture  of 
microsomes and  Golgi elements was  obtained  by  cen- 
trifuging the ensuing supernate of 105,000 g for 90 rain. 
The pellet was suspended in a  small volume of 0.25 M 
sucrose and sufficient 2.1 M sucrose was added to obtain 
a  1.17 M  sucrose  concentration. All  sucrose  solutions 
were  checked in a  refractometer to assure correct final 
sucrose concentrations. Three Golgi fractions were iso- 
lated  from  this suspension by the procedure of Ehren- 
reich et al.  (9) with a  few  modifications: an additional 
sucrose layer (I.15 M) was introduced between the load 
and the rest of the discontinuous gradient and centrifuga- 
tion was carried  out  for 3 h  at 81,750 g,v~. To obtain 
SER and RER fractions, the load fraction and the pellet 
were further processed by pooling and diluting them with 
TKM buffer (10 mM Tris-HCl pH 7.4, 25 mM KCl,and 
5 mM MgCI2) to a sucrose concentration of 0.25 M and 
by harvesting them as a pellet by centrifugation at 50,000 
rpm  (Spinco 50 Ti)  for  1 h; this mixture of RER  and 
SER  was then further fractionated by the procedure of 
Ragland et al. (28). 
Preparation  of Samples for 
lmmunoprecipitation Assays 
The  three  Golgi  fractions  and  the  RER  and  SER 
fractions were removed from discontinuous gradients and 
were  diluted  with  TKM  to  obtain  a  final  sucrose 
concentration  of  0.25  M.  Particles  were  pelleted  by 
centrifugation at 50,000 rpm (Spinco 50 Ti) for I h. The 
pellets were  resuspended  in 0.154  M  NaCI  with TKM 
and sodium deoxycholate was added to a final concentra- 
tion of 0.5%. At this concentration, the detergent releases 
all  the  radioactive  albumin  and  ~90%  of  the  total 
acid-insoluble radioactivity sequestered within, or associ- 
ated with, ER and Golgi vesicles. The concentration was 
chosen for convenience: it causes extensive solubilization 
of  membranes,  disperses  the  contents,  and  does  not 
interfere with the antibody-antigen reaction. The samples 
were then cleared of nonsolubilized material by centrifu- 
gation  at  50,000  rpm  (Spinco  50  Ti)  for  I  h.  When 
determining  the  amounts  of  plasma  protein  in  the 
homogenate, a  sample corresponding to 0.1  g liver was 
diluted with 0.154  M  NaC1  in TKM  to  10 ml and was 
then treated with 0.5% sodium deoxycholate and cleared 
of  insoluble  material  by  centrifugation.  The  soluble 
cytoplasmic fraction was not treated with sodium deoxy- 
cholate but it was buffered with 0.01  M Tris-HCl pH 7.4 
and 0.154 M NaCI. The medium in which slices had been 
incubated  was  used  without  further  treatment_  Blood 
samples  were  heparinized  and  the plasma obtained  by 
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in TKM. 
Immunoprecipitation Assays 
Radioactivity in albumin and in other plasma proteins 
was  determined  as  previously  described  (29,  30).  Re- 
cently it was reported that intracellular albumin obtained 
by  immunoprecipitation  is  chemically  different  from 
plasma albumin and may represent an albumin precursor 
(15,  33).  Antibodies to  rat  plasma  proteins other than 
albumin  were  prepared  by  absorbing out  the  anti-rat 
albumin  from  an  antibody  preparation  to  total  rat 
plasma  protein,  using  the  method  of  Avrameas  and 
Ternynck ( 1  }. 
Other Procedures 
Radioactive samples, either TCA-precipitated protein 
or antibody-antigen complexes, were dissolved in 1 ml of 
Soluene plus 0.1  ml of glacial acetic acid, and  10 ml of 
toluene  scintillation  phosphor  were  added  before 
counting in a Packard scintillation radiometer. 
Protein  was  assayed  by the method of Lowry et al. 
(18),  with bovine plasma albumin as a standard. 
The  specific  activity  of  nucleotide  phosphates  was 
determined by adsorption of the nucleotides from a 5% 
TCA-soluble fraction on charcoal and hydrolysis of the 
adsorbed material in  I  N  HCI for  10 rain at  100~  as 
described by Crane and Lipmann (6). Phosphorus analy- 
sis was performed by the method of Bartlett (2). 
Electron  Microscopy 
Liver samples from control or treated rats were fixed 
either in  1% OsOo in 0.1  M cacodylate buffer or in 2.5% 
formaldehyde-2%  glutaraldehyde  in  the  same  buffer 
followed by l%OsO,. The tissues were stained in block in 
uranyl acetate before dehydration in graded ethanols and 
finally embedded  in  Epon.  Thin  sections  stained  with 
uranyl  acetate  and  lead  citrate  were  examined  in  a 
Siemens Elmiskop  102. Golgi fractions were  processed 
for electron microscopy as previously described (9). 
Sources of Material 
L-[U-~'C]Leucine (348 Ci/mmol) was purchased from 
Amersham/Searle Corp.,  Arlington  Heights,  I11.; [me- 
thoxv-"C]colchicine (15  Ci/mmol) was  obtained  from 
New England Nuclear, Boston, Mass. Vinblastine sulfate 
was a kind gift from Eli Lilly and Company, Indianapo- 
lis,  Ind. Colchicine was bought from  Sigma Chemical, 
Co., St. Louis, Mo.; griseofulvin from Aldrich Chemical 
Co.,  Inc.,  Milwaukee,  Wis.,  and  cytochalasin  B  from 
Gallard-Schlesinger Chemical Mfg. Corp., Carle Place, 
N.  Y.  Lumicolchicinr  was prepared and given to us by 
Dr. M. Rifkin of The Rockefeller University, New York. 
RESULTS 
Effect of Colchicine and Vinblastine 
on the Secretion  of Plasma Protein 
(Albumin) by Liver Slices 
The  initial  observations,  which  showed  that 
colchicine  and  vinblastine inhibit  secretion,  were 
performed  on  liver  slices  pulse  labeled  with  L- 
[~4C]leucine  for  7-9  min,  then  transferred  to  a 
"chase"  medium  containing  nonradioactive  leu- 
cine and 5  x  10 -~ M  colchicine or vinblastine. In 
control  slices,  radioactive  TCA-precipitable  pro- 
tein  began  to  appear  in  the  medium  after  a 
15-20-min chase and continued to accumulate for 
2  h.  In  the  presence  of colchicine or  vinblastine, 
there was a 40-70% inhibition at all time points of 
the amount of radioactive protein secreted by the 
slices (Fig.  1). The inhibitory effect appeared to be 
unique  to  colchicine  and  vinblastine:  lumicolchi- 
cine,  a  structural  isomer  of  colchicine,  was  five 
times  less  effective  at  10 -~  M  (which  is  the 
concentration at which colchicine showed maximal 
inhibitory  activity).  Lumicolchicine  is  contami- 
nated  by  3%  colchicine,  as  shown  by  spectral 
analysis, and this may explain, at least in part, the 
effect  observed.  Cytochalasin  B  at  4.8  x  10  -5- 
4.8  x  10 -4  M  and  griseofulvin  at  10-6-10 -.  M 
did not inhibit secretion (Table I). 
The inhibitory effect of colchicine was noticed at 
concentrations as low as  10 -e  M,  with a  maximal 
effect  at  10  -~  M.  Fig.  2  shows  an experiment  in 
which  secretion into the medium  as well as reten- 
tion of albumin within the slices was measured at 
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Time-course of protein secretion by rat liver 
slices:  effects  of  colchicine  and  vinblastine.  Rat  liver 
slices were  pulse  labeled for 9  min with L-["C]leucine 
and were then chased with nonradioactive amino acid for 
the times indicated.  Details are presented in Materials 
and Methods. Colchicine and vinblastine were introduced 
in the chase medium at a final concentration of 5 x  l0  -b 
M. 
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Effect of Colchicine, Lumicolchicine,  Cytochalasin 
B, and Griseofulvin on Plasma Protein Secretion by 
Rat Liver Slices 
Plasma 
protein 
secreted 
(epm/mg 
slice  lnhibi- 
Additions to chase medium  protein)  tion 
M  % 
Exp 1 
Control  316 
Dimethyl sulfoxide  304  4 
Cytochalasin B  4.8 x  10  -6  312  1 
Cytochalasin B  2.4 ￿  10  -s  315  0 
Cytochalasin B  4.8 ￿  10  -~  285  10 
Colchicine  5.0 ￿  10  -~  108  66 
Exp 2 
Control  120 
Lumicolchicine  5 ￿  10  -6  i 10  8 
Lumieolchicine  10  -5  108  10 
Lumicolchicine  2.5 x  10  -6  101  16 
Lumicolchicine  3.0 ￿  10  -5  95  21 
Colchicine  10  -5  44  63 
Colchicine  2.5 ￿  10  -s  36  70 
Exp 3 
Control  155 
Griseofulvin  10- e  14 i  9 
Griseofulvin  10  -5  156  0 
Griseofulvin  10-'  173  0 
Colchicine  10  -~  56  6,1 
Rat liver slices were pulse labeled with L-['C]leucine  for 
9  min  and  then  chased  with  nonradioactive  medium 
containing the above concentration of drugs for 180 rain 
in exp.  1 and  60  min  in exps.  2  and  3.  The  proteins 
secreted  into  the  chase  medium  were  determined  by 
immunoprecipitation. Dimethyi sulfoxide was used as a 
solvent  for  cytochalasin  B  and  griseofulvin.  The  final 
concentration  was  0.028  M.  These  are  representative 
experiments from a series of three for each drug concen- 
tration. 
different concentrations of colchicine and vinblas- 
tine:  the inhibition of secretion  was accompanied 
by a  concomitant  retention of albumin within the 
slices, presumably in the hepatocytes. 
The  colchicine  and  vinblastine effect  on  secre- 
tion was not the result of an inhibition of protein of 
protein synthesis. When liver slices were incubated 
in the presence of L-['C]leucine and 5  x  10  -~  M 
colchicine or vinblastine, there was no effect on the 
initial rates of protein synthesis as measured by the 
incorporation of radioactivity into TCA-precipita- 
ble protein. Vinblastine at  10 -4 M  showed a  small 
inhibitory effect at  1 h of incubation but colchicine 
did not (Fig.  3). 
In  Vivo Effects of Colchicine 
Colchicine,  given  intravenously,  (7-25  /~mol/ 
100  g  of  body  weight)  inhibited  the  secretion 
of albumin in the plasma, and caused concomitant 
accumulation  of albumin within the liver in intact 
animals  (Fig.  4).  The  rats  tolerated  doses  of 25 
~mol/100 g  of body  weight quite  well,  but doses 
higher than 30 umol/100 g  body weight occasion- 
ally  caused  death,  especially  if the  rats had  been 
fed alcohol. 
Radioactive albumin appears in the blood 15-20 
min  after  the  injection  of L-['C]ieucine.  Colchi- 
cine  inhibited  secretion  from  the  onset  and  the 
effect persisted  for 3  h  (Fig.  5).  Albumin was not 
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Effect of various concentrations of colchicine 
and vinblastine on albumin secretion by rat liver slices. 
Rat  liver slices were  incubated as  in  Fig.  1.  The chase 
incubation  was  carried  out  for  90  rain.  Radioactive 
albumin,  secreted  into  the  medium  or  retained  within 
slices,  was  determined  as  described  in  Materials  and 
Methods. 
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tion of all the other plasma proteins was similarly 
inhibited. This was determined by immunoprecipi- 
tation  using  two  different  antisera;  one  which 
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FIGURE  3  Incorporation  of L-[~'C]leucine  into TCA- 
precipitable  protein  by  rat  liver slices.  Rat  liver slices 
were incubated with L-[~'C]leucine as described in Mate- 
rials and  Methods. Colchicinr  or vinblastine (5  ￿  l0 -s 
M) was added  at zero time and the slices were incubated 
for varying times up to I h. At the end of incubation the 
slices and the incubation medium were homogenized and 
total  TCA-precipitable  radioactivity  was  determined. 
Thus the points represent radioactivity (epm ￿  l0 -2) per 
milligram total protein in both medium and tissue. 
reacted  with  rat  albumin  and  another  which  re- 
acted  with  all  the  rat  plasma  proteins  except 
albumin.  Since colchicine has  also  been  shown to 
inhibit  hepatic  secretion  of  VLDL  (17,  36),  it 
appears  to  act  as  a  general  inhibitor  of  the 
secretion  of all plasma proteins by the liver. 
The effect of colchicine on secretion is prompt as 
shown  by  the  results  of the experiment in Fig,  6. 
Colchicine (25 gmol/100 g body weight) was given 
33  rain after an initial injection of L-[~C]leucine, a 
time at  which there is linear secretion of albumin. 
Within  2 rain  after the administration  of the drug 
there  was  a  noticeable  reduction  in  the  rate  at 
which  albumin  was  secreted  into the plasma.  An 
equally  prompt  effect was  obtained  when  colchi- 
cine was injected at 42 rain after the administration 
of  L-[~4CJleucine  (not  shown)  at  a  time  when 
secretion of radioactive albumin begins to subside, 
Lack of Effect Of Colchicine on the 
Nucleotide Phosphate Levels 
In  a  previous  experiment  it  was  shown  that 
colchicine  did  not  affect  albumin  secretion  by 
inhibiting protein synthesis (Fig, 3). Secretion may 
be  inhibited,  however,  by  drug  interference  with 
cellular  energetics,  primarily  a  decrease  in  the 
intracellular  concentration  of ATP. To determine 
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FIGURE 4  In vivo inhibition of albumin secretion  by colchicine. Varying amounts of colchicinc (in a 0.15 
M  saline  solution) were  injected  intravenously into rats.  This was  followed immediately with  a  second 
injection of 7.5/~Ci/100 g body weight of L-[~4C]leucine. 45 rain after the administration of the radioactive 
leucine,  a  sample of blood was taken  from the rat by heart  puncture and the livers were  removed. The 
amount of radioactive albumin in the liver and in plasma was determined as described in Materials and 
Methods. 
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FIGURE 5  In vivo secretion  of albumin and other serum 
proteins: effect of colchicine.  Colchicine (25 t=mol/100  g 
body weight) was injected  into the femoral vein of a rat, 
followed closely by a second  injection of 12.5/~Ci/100 g 
body weight of L-[t~C]leucine. Control rats received an 
equal volume of saline instead of colchicine.  At specified 
times the rats were bled  from the tail vein and  75/~1 of 
blood were placed in 3 ml of 0.154 M NaCI in TKM. The 
blood  cells  were  removed  by  centrifugation  and  the 
supernate was used to determine radioactive albumin or 
other  serum  proteins  as  described  in  Materials  and 
Methods.  Fig. 5 A describes the appearance of radioac- 
tive albumin  in  plasma  and  Fig.  5 B that  of the other 
proteins. 
if this is the case, radioactive inorganic phosphate 
was  injected  into  control  and  colchicine-treated 
rats and at various times both the entry of 32P 1 into 
the  liver and  its conversion  into  nucleotide phos- 
phates were determined. Neither the specific activ- 
ity  of  the  a~p,  nor  its  conversion  to  nucleotide 
phosphate  was affected by colchicine (Fig. 7). 
lntracellular Localization  of the 
Colchicine Effect 
Since colchicine causes an inhibition of secretion 
and  an  accumulation  of  the  secretory  products 
within the cell (Fig. 2), it was of interest to find out 
in  what  intracellular  compartment  the  accumula- 
tion  occurs.  To  this  intent,  rats  were  injected 
intravenously  with  L-[l'C]leucine  and  at  various 
time intervals after the onset of radioactive protein 
synthesis,  the  livers were  removed,  homogenized, 
and  fractionated.  In  some  experiments  the  rats 
were  fed  alcohol  since  this  has  been  shown  to 
increase the yield and purity of Golgi fractions (9). 
Table  II  shows the cell fractions isolated  in these 
experiments  and  the  average  yields  from  control 
and  from  colchicine-treated  rats.  The  yield  of 
Golgi fractions  varied from experiment to experi- 
ment  but  in  all cases  larger amounts  of the three 
Golgi fractions could be obtained from alcohol-fed 
rats  than  from  normal  rats.  With  or  without 
ethanol  pretreatment  of  the  animals,  colchicine 
caused  a  general  increase  in  the  yield  of hepatic 
Golgi fractions.  The  morphology  of the fractions 
isolated from ethanol-treated or colchicine-treated 
rats  was almost the same, except that  the vesicles 
of the light and  intermediary Golgi fractions were 
smaller  and  had  a  lower load  of VLDL particles 
after colchicine than after ethanol.  Fig. 8-10 show 
that  the Golgi fractions obtained  from colchicine- 
treated  animals  are reasonably  homogeneous and 
consist essentially of recognizable Golgi elements. 
The effect of colchicine in increasing the amount 
of radioactive albumin within the Golgi fractions is 
demonstrated  in  Figs.  11-14.  This  experiment 
shows that the amount of radioactive albumin per 
gram  liver  and  per  milligram  of  cell  fraction 
protein  is  greatly  enhanced  in  the  three  Golgi 
fractions,  but  that  colchicine  does  not  alter  the 
nascent  albumin  concentration  in  the  other  cell 
fractions.  Using  the  data  on  Table  II  and  Figs. 
11-14  we can  calculate that  there is little leakage 
of albumin from the cell fractions, since only 2-3% 
of  radioactive  albumin  is  recovered  in  the  final 
supernate;  and  we can  also conclude  that  there is 
good drainage  of newly synthesized albumin from 
the ER into the Golgi elements since 38-58% of its 
total  can  be  recovered  at  this  time  in  the  Golgi 
~5 
_  4 
'O 
-  5 
x 
~2 
-~ 
o' 
,/ 
o 
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20  30  40  5O 
MINUTES 
FIGURE  6  Time-course  of  the  inhibition  of  albumin 
secretion  by  colchicine  in  vivo.  12.5 /~Ci/100  g  body 
weight of L-[U-'=C]leucine  was injected  into the femoral 
vein  of  rats  at  zero  time.  Saline  or  colchicine  (25 
#mot/100 g body weight) was injected at 33 min after the 
administration of L-[U-"C]leucine (arrows).  Blood sam- 
ples were taken  from the tail at the specified  times and 
the  amount  of radioactive albumin  in  the  plasma  was 
determined by immunoprecipitation. 
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FIGURE  7  Specific radioactivities of  intracellular  nucleotide phosphates  in  response to  colchicine. 
Experimental animals received intravenously (femoral vein) 25 tsmol/100 g body weight colchicine and 2 
min after it s2Pt (25 laCi/100 g body weight) in saline. Control rats received saline instead of colchicine.  At 
the specified times, the livers were removed, rinsed in 0.25 M sucrose, and homogenized in ice-cold 5% 
TCA. The specific radioactivities of the nucleotide phosphates and of the intracellular inorganic phosphate 
were determined from the TCA-soluble fraction (6). 
fractions, with  the  remainder in the smooth and 
rough  microsomes.  This  is  in  contrast  to  the 
recoveries of TCA-precipitable radioactivity where 
58-64%  is found in the soluble cytoplasmic frac- 
tion and only 9-14% in Golgi elements. 
A time-course study showed that there was peak 
albumin radioactivity at  10 min after the adminis- 
tration of radioactive leucine (to  the  rat)  in the 
rough  microsomes and  at  30  min in the  smooth 
microsomes  and  the  Golgi  fractions  (Fig.  15). 
Colchicine treatment did not affect the movement 
of albumin radioactivity in the RER or SER nor 
the  rate  of entry of radioactive albumin into the 
Golgi fractions (see  10- and 20-min time points); it 
did affect, however, the rate of release of albumin 
from the Golgi fractions. In control rats, there was 
a  gradual  loss  of  radioactive  albumin from  the 
Golgi  fractions  after  30  min but  the  colchicine- 
treated  rats  retained  the  radioactive  albumin in 
these fractions for the duration of the experiment 
(90 min). The radioactive albumin from the light 
Goigi fraction (Golgi  I) is not shown  in Fig.  15 
because  at  some  of  the  time  points  in  these 
experiments alcohol-fed  rats  were  not  used  and 
insufficient and  often  variable yields of Golgi  I 
were obtained. We do, however, have information 
on the amounts of radioactive albumin in Golgi I 
at  45,  60,  and  90  min,  and  at  these  times  the 
colchicine effect  is  similar  to  that  seen  in  the 
intermediate Golgi fraction (Golgi II). 
Since coichicine does not affect the transport of 
nascent albumin in the ER, nor does it affect the 
filling of the Golgi vesicles  with albumin, then it 
must  be  acting at  a  stage  in  secretion  after  the 
Golgi-derived secretory  vesicles  have  been  filled 
but before their fusion with the plasma membrane. 
Hepatocyte Morphology 
By  comparison  with  their  corresponding con- 
trois, the hepatocytes of colchicine-treated animals 
(25 #mol/100 g body weight) have Golgi elements 
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Recovery  of Liver Cell Fractions from Colchicine- 
and AIcohol- Treated Rats 
Proteins in cell  fractions (mg/g liver) 
Alcohol 
Colchi-  and col- 
Control  cine  Alcohol  chicine 
Homogenate  190.5  193.2  196.7  199.7 
Fractions 
Soluble  39.5  37.8  36.5  40.8 
RER  6.31  5.60  7.07  5.95 
SER  5.49  5.29  5.44  5.70 
Golgi I  0.08  0.11  0.12  0.17 
Golgi II  0.28  0.33  0.35  0.54 
Golgi III  1.18  1.22  1.39  1.61 
Average of four experiments.  RER, rough microsomal 
fraction; SER, smooth microsomal fraction; Golgi I, II, 
and  III, light, intermediate,  and heavy Golgi fractions, 
respectively.  Cell fractionation  was  performed  as de- 
scribed  in  Materials  and  Methods.  The  low  protein 
recovery  (about  25%  of the  homogenate  proteins re- 
covered in the sum of the fractions listed) reflects heavy 
losses  of microsomes  and  Golgi elements  at  the  first 
centrifugation  of the homogenate. 
with a higher load of VLDL particles (Fig. 16) and 
a  large population of VLDL-containing secretion 
vacuoles (Figs.  16-18).  The  latter,  besides being 
concentrated along the sinusoidal front of the cells 
(Fig.  17), are also found scattered throughout the 
cytoplasm (Fig.  18). The secretion vacuoles show 
considerable variation in  size and compaction  of 
content and in many of them the VLDL particles 
appear embedded in a homogeneous dense matrix. 
In ethanol-treated rats, the VLDL load of Golgi 
elements is more pronounced  and the concentra- 
tion of secretion vacuoles higher in Golgi regions 
than in the rest of the cytoplasm (9). 
In  the  hepatocytes  of  control  animals,  mi- 
crotubules are found in  the Golgi regions and in 
the peripheral cytoplasm but their concentration is 
low and  their distribution is apparently random, 
without any indication of special relationship with 
secretion vacuoles. Neither the concentration nor 
the  arrangement  of  microtubules  seems  to  be 
affected  by  colchicine treatment  at  a  time (1  h) 
when  inhibition  of  plasma  protein  secretion  is 
already  maximal.  In  fact,  microtubules  are  still 
detected  in  Golgi regions,  along  bile capillaries, 
and along the sinusoidal front of the hepatocytes 3 
h after the administration of the drug (Figs. 19 and 
20). 
DISCUSSION 
The effect of colchicine on the general physiology 
of the  liver  has  been  studied  in  some  detail  in 
perfused  preparations.  The  results  indicate  that 
colchicine at  10 uM concentration does not affect 
glucose production, intracellular ATP levels, oxy- 
gen consumption, protein and lipid synthesis, nor 
ureogenesis  but  causes  a  marked  inhibition  of 
VLDL  release  (17).  Cotchicine  has  also  been 
shown  to  inhibit  VLDL  release to  the extent  of 
50-80%  in  intact  rats  pretreated  for  3  h  with 
0.25-2.5 umol of drug/100 g body weight (36). 
Our studies show that colchicine and vinblastine 
inhibit the  secretion  of plasma proteins  by  liver 
cells both in vivo (Figs. 4 and 5) and in vitro (Figs. 
1  and  2).  Concomitant  with  reduced  secretion, 
these drugs caused an accumulation of the nonse- 
creted proteins within the cell (Figs. 2 and 4).  in 
the intact animal the colchicine effect is prompt; it 
is detected within minutes (Fig. 4), and it is durable 
(Fig.  5).  The  sites  of accumulation  of secretory 
proteins, as shown  by cell fractionation and elec- 
tron microscopy of intact liver cells, are the Golgi 
complex  and  Golgi-derived  secretory  vacuoles. 
Intracellular  transport  of  secretory  proteins  in 
liver proceeds  from  RER  to  SER,  to  the  Golgi 
complex (26). The time-course presented in Fig. 15 
confirms this progression except that a time inter- 
val between smooth microsomes and heavy Golgi 
fraction  (Golgi  Ill)  is  not  resolved.  The  data 
suggest  that  the  transit  from  SER  to  the  Golgi 
complex is so rapid that kinetic differences can be 
obscured by individual variations among animals 
and possibly by some cross-contamination between 
the corresponding cell fractions. The experiments 
show, however, that colchicine does not affect the 
movement of secretory proteins in the RER or the 
SER, nor does it affect filling of the Golgi vesicles; 
it impedes instead discharge and leads to accumu- 
lation  of secretory protein  in  all Golgi elements 
(Figs. 8-18). 
The  mechanism  by which colchicine elicits this 
response  is not  known.  We  have  shown  that  the 
effect is due neither to a decrease in the intracellu- 
lar level of nucleotide phosphates (Fig. 7) nor to an 
impairment of protein synthesis (Fig. 3). 
Since colchicine has a  high specific affinity for 
tubulin  and  inhibits  tubulin  polymerization into 
microtubules  (3,  4),  the  effects  of this  drug  on 
several secretory systems have been ascribed to its 
interaction  with  microtubules (19,  23).  The  data 
show that the effect of colchicine on secretion, like 
REDMAN ET  AL.  Colchicine Inhibition of Plasma Protein  49 FIGURES 8  10  Golgi fractions isolated from colchicine-treated rats 1 h after the administration of the drug 
(25  tamol/100  g  body  weight).  Representative  fields  in  sectioned  pellets.  At  3  h  after  colchicine  the 
appearance of the fraction is the same except for the VLDL load which is heavier. 
FIGURE 8  Golgi I. The preparation is homogeneous and consists of numerous rounded secretion vacuoles 
(sv) and relatively few cisternae (cs), all filled and marked by VLDL particles embedded in an amorphous 
dense matrix; (svO marks secretion vacuoles which have lost part of their VLDLs.  ￿  37,000. FIGURE 9  Golgi I1. The predominent elements are still secretion vacuoles (sv) and cisternal elements (cs). 
They are of generally smaller size than in Golgi i  and many appear to have lost in part their VLDL con- 
tent (sv~).  x  37,000. 
51 FIGURE  10  Golgi  Ili.  The  dominant elements in this fraction are  flattened Golgi cisternae {cs)  with 
slightly distended rims occasionally marked by VLDL particles. The intraceilular origin of the large empty 
vacuoles (v) is uncertain,  x  36,000. 
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FIGURES  l J  and  12  Intracellular  distribution  of  ra- 
dioactive TCA-precipitable protein in rat liver 1 h after 
the administration of L-[U-l'C]leucine. Rats  were  in- 
jected  with  25 t~mol/100  g  body weight  of colchicine; 
control rats  received  an equal volume of saline. Both 
colchicine  and saline were  followed  by the administra- 
tion  of  12.5 vLCi/100 g  body  weight  of  L-[U-I'C]  - 
leucine. All in~ections were given in the femoral vein, 1 h 
after  administration of  L-[l'C]leucine the  livers  were 
removed  and cell  fractionation was  performed  as de- 
scribed  in Materials and Methods.  Rats were fed alco- 
hol by stomach tube 30 rain before the administration of 
L-[ ]'C]leucine. 
FIGURE  11  Describes  the  results  in  terms  of radio- 
activity  of TCA-precipitable protein  in  the  cell  frac- 
tions obtained from  I g of liver. The homogenate frac- 
tion of control animals contained 454,800  cpm/g liver 
and  that  of colchicine-treated  rats  contained 497,500 
cpm/g liver. 
its  effect  on  tubulin, is  "specific,"  since  plasma 
protein  secretion  is not inhibited by: (a) lumicol- 
chicine, which does not bind to tubulin, (b) griseo- 
fulvin, an antimitotic agent which does not block 
the in vitro polymerization of tubulin (43), and (c) 
cytochalasin B which does not bind to tubulin but 
inhibits  glucose  uptake  (20  and  is  thought  to 
disorganize microfilaments (40). 
There is, however,  little evidence in normal rat 
hepatoc.ytes of microtubule concentration and spe- 
cial  orientation at  the  discharge  sites,  where  we 
have localized the colchicine effect; and in our in 
vivo experiments microtubules are still recogniza- 
ble  in  the  Golgi  region,  in  the  vicinity  of  bile 
capillaries,  and  along the  sinusoidal front  of the 
hepatocyte,  after  coichicine treatment  (see,  how- 
ever, reference 17 for opposite findings.). There is, 
therefore,  no  consistent  correlation  between  mi- 
crotubule depolymerization and  secretory  inhibi- 
tion, but more subtle effects limited to the point of 
interaction of microtubules with the plasma mem- 
brane cannot be ruled out. 
Besides  tubulin  binding,  colchicine  has,  how- 
ever,  multiple cellular effects  which  may  be  in- 
volved in the secretory inhibition described. It has 
been claimed that  it  binds to  isolated membrane 
fractions (1 I, 35), it seems to affect the distribution 
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FIGURE  I2  Gives  the  same  results  as  TCA-precipi- 
table  radioactivity per  milligram of protein  from  the 
isolated  cell fraction. The recoveries  of protein in cell 
fractions isolated  from  l g of liver are shown in Table II. 
The solid  bars represent colchicine  (or  alcohol  +  col- 
chicine)-treated  rats;  the  cross  bars  represent  control 
(or alcohol-treated) rats.  RER, rough  microsomal frac- 
tion;  SER,  smooth  microsomal  fraction;  S,  final 
supernate; H, homogenate. 
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FIGURES  ]3  and  14  Distribution  of  nascent  albumin 
in  rat  liver  ]  h  after  L-[U-l'C]leucine  administration: 
effect of colchicine. The experimental protocol was the 
same as for Figs. 11 and  12 except that radioactivity was 
determined  in  the  albumin  present  in  the  various  cell 
fractions, instead of in TCA-precipitable proteins. Solid 
bars refer to colchicine (or alcohol +  colchicine)-treated 
rats,  and  the  cross bars  represent control (or  alcohol- 
treated) animals.  As in  Figs.  11  and  12  the data in the 
top  figure  were  obtained  from  normal  rats  and  the 
bottom figure from alcohol-fed rats. In Fig.  13 the data 
are  normalized per gram  liver,  whereas in  Fig.  14  the 
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FIGURE  15  Time-course of distribution  of nascent al- 
bumin  in  various  liver  cell  fractions  in  control  and  in 
colchicine-treated rats. Rats were treated as described in 
the legend of Figs. 11 and 12, and the livers were removed 
at the specified times after the injection of L-[U-"C]leu- 
cine. Each time point represents a different experiment. 
The  dotted  lines  represent  the  amounts  of  nascent 
albumin  in  colchicine-treated  rats  and  the  solid  lines 
represent nascent albumin in the control animals. For the 
designation of the cell fractions, see the legend of Figs. I I 
and  12. 
results  are  expressed  per  milligram  cell  fraction  pro- 
tein.  For  the  designation  of the  cell  fractions,  see the 
legend of Figs. I 1 and  12. 
FIGURES 16-18  Hepatocytes  I  or 3  h  after administration  of colchicine in  vivo (25  vmol/100 g  body 
weight). All specimens were fixed by perfusion with glutaraldehyde-formaldehyde and postfixed in OsO, 
as indicated in Materials and Methods. 
FIGURE 16  Golgi region in the vicinity of a  bile capillary (be).  The cisternal elements (cs)  of the Golgi 
complex are partially filled with VLDL particles. The rest of the Golgi region is occupied by numerous 
VLDL-containing secretion vacuoles (sv).  Lysosome, Iv;  lysosome formed in connection with an  auto- 
phagic vacuole, lyl;  lipid droplet, l.  ￿  41,000. 
FIGURE 17  Cell periphery on the sinusoidal front of the cell. Cluster of VLDL-containing secretion vac- 
cuoles, sv; space of Disse, sd.  ￿  49,000. 
THE JOURNAL OF CELL BIOLOGY  . VOLUME 66,  1975 REDMAN  ET  AL,  Colchicine Inhibition of Plasma Protein  55 FIGURE 18  Large  field  in the cytoplasm of a  hepatocyte  containing numerous secretion  vacuoles  (sv) 
filled with VLDL particles.  Sinusoidal front of the cell, sf; peroxisome, p.  x  32,000. 
of intramembrane particles in Tetrahyrnena pyri- 
formis  (44),  it  causes  a  redistribution  of  lectin- 
binding sites on the membrane of leukocytes (22), 
and it has been shown to  affect  nucleoside trans- 
port promptly and drastically (20, 39). Vinblastine 
modifies the behavior of erythrocytes in hypotonic 
hemolysis  presumably  by  accumulating  in,  and 
expanding, their plasmalemma (34). 
With the evidence available, we cannot ascribe 
the inhibitory effect  of colchicine on plasma pro- 
THE  JOURNAL  OF  CELL  BIOLOGY  . VOLUME 66,  1975 FIc3utE  19  Golgi region and vicinity of a bile capillary (bc) in a hepatocyte 3 h after colchicine adminis- 
tration (25/~mol/100 g body weight). Four microtubules (arrows) traverse the region at various angles; 
microfilaments appear in bundles at some distance from the cell surface, or as a  feltwork immediately 
under the plasmalemma. Microvilli in the bile capillary, my.  ￿  80,000. 
FIGURE 20  Periphery  of a  hepatocyte along the  sinusoidal front.  Space  of Disse,  sd;  lysosomes, ly. 
Lysosomes of the type illustrated in this field as well as autophagic vacuoles appear to increase in fre- 
ouency  in colchic|ne-treated animals.  A  microtubule runni~g parallel to  the cell surface  is marked by 
arrows.  ￿  50,000. tein secretion to microtubule depolymerization, or 
to  a  direct  effect  on  the  metabolism  of  the 
hepatocyte. The inhibitory mechanism remains to 
be explained by  further studies. The experiments 
which  we  have  described,  however,  localize  the 
colchicine effect at a post-Golgi stage and indicate 
that  the  drug  acts  by  hampering  discharge  of 
secretory  proteins  from  Golgi-derived  secretory 
vacuoles into the space of Disse. 
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